BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 16035296)

  • 1. [Adipocytokines: link between obesity, type 2 diabetes and atherosclerosis].
    Paquot N; Tappy L
    Rev Med Liege; 2005; 60(5-6):369-73. PubMed ID: 16035296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.
    Choi KC; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH; Choi KM
    Biochem Biophys Res Commun; 2005 Oct; 336(3):747-53. PubMed ID: 16157299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of adipocytokines and insulin resistance.
    Fasshauer M; Paschke R
    Diabetologia; 2003 Dec; 46(12):1594-603. PubMed ID: 14605806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Role of Adipocytokines in Type 2 Diabetes as Mediators of Insulin Resistance and Cardiovascular Disease.
    Jaganathan R; Ravindran R; Dhanasekaran S
    Can J Diabetes; 2018 Aug; 42(4):446-456.e1. PubMed ID: 29229313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adiponectin: a new adipocytokine].
    Lebas E; Paquot N; Scheen AJ
    Rev Med Liege; 2003 Sep; 58(9):554-8. PubMed ID: 14626649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipocytokines: leptin--the classical, resistin--the controversical, adiponectin--the promising, and more to come.
    Koerner A; Kratzsch J; Kiess W
    Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):525-46. PubMed ID: 16311215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adipocytokines: factors with various suggested functions].
    Zhu Y; Huang D
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Apr; 27(2):476-80. PubMed ID: 20481343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiponectin and atherosclerotic disease.
    Shimada K; Miyazaki T; Daida H
    Clin Chim Acta; 2004 Jun; 344(1-2):1-12. PubMed ID: 15149866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance.
    Monzillo LU; Hamdy O; Horton ES; Ledbury S; Mullooly C; Jarema C; Porter S; Ovalle K; Moussa A; Mantzoros CS
    Obes Res; 2003 Sep; 11(9):1048-54. PubMed ID: 12972674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin: a link between excess adiposity and associated comorbidities?
    Ukkola O; Santaniemi M
    J Mol Med (Berl); 2002 Nov; 80(11):696-702. PubMed ID: 12436346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipose expression of adipocytokines in women with polycystic ovary syndrome.
    Svendsen PF; Christiansen M; Hedley PL; Nilas L; Pedersen SB; Madsbad S
    Fertil Steril; 2012 Jul; 98(1):235-41. PubMed ID: 22607892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in insulin resistance following bariatric surgery and the adipoinsular axis: role of the adipocytokines, leptin, adiponectin and resistin.
    Ballantyne GH; Gumbs A; Modlin IM
    Obes Surg; 2005 May; 15(5):692-9. PubMed ID: 15946462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss.
    Milan G; Granzotto M; Scarda A; Calcagno A; Pagano C; Federspil G; Vettor R
    Obes Res; 2002 Nov; 10(11):1095-103. PubMed ID: 12429872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifestyle modification and endothelial function in obese subjects.
    Hamdy O
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipocytokines: fat-derived humoral mediators of metabolic homeostasis.
    Staiger H; Häring HU
    Exp Clin Endocrinol Diabetes; 2005 Feb; 113(2):67-79. PubMed ID: 15772897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin and metabolic syndrome.
    Matsuzawa Y; Funahashi T; Kihara S; Shimomura I
    Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):29-33. PubMed ID: 14551151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance and inflammation in the early phase of type 2 diabetes: potential for therapeutic intervention.
    Schernthaner GH; Schernthaner G
    Scand J Clin Lab Invest Suppl; 2005; 240():30-40. PubMed ID: 16112958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity.
    Vendrell J; Broch M; Vilarrasa N; Molina A; Gómez JM; Gutiérrez C; Simón I; Soler J; Richart C
    Obes Res; 2004 Jun; 12(6):962-71. PubMed ID: 15229336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity, adipocytokines, and insulin resistance in breast cancer.
    Rose DP; Komninou D; Stephenson GD
    Obes Rev; 2004 Aug; 5(3):153-65. PubMed ID: 15245384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.